Modulation of Lipoprotein Cholesterol Levels in Plasmodium berghei Malarial Infection by Crude Aqueous Extract of Ganoderma lucidum

Table 3

Liver TC, LDL-, HDL-, and VLDL-cholesterol levels in Plasmodium berghei-infected mice treated with aqueous extract of Ganoderma lucidum.

Treatment groups		TC	LDL	HDL	VLDL
Controls	Normal	66.03 ± 6.97^a	37.51 ± 3.82^a	12.67 ± 0.01^a	15.85 ± 0.06^a
	Infected	171.78 ± 8.70^b	99.25 ± 8.46^b	31.31 ± 0.01^b	41.22 ± 0.02^b
Aqueous extract	AQ100	146.42 ± 4.34^c	93.70 ± 2.78^b	19.29 ± 0.25^c	33.68 ± 0.02^c
	AQ250	150.94 ± 9.54^b,c	96.60 ± 6.10^b	16.60 ± 0.11^d	37.74 ± 0.02^d
	AQ500	172.00 ± 8.35^b	110.08 ± 5.34^b	22.36 ± 0.01^e	39.56 ± 0.06^e
Reference drug	CQ	111.56 ± 4.99^d	71.40 ± 3.19^c	13.39 ± 0.01^f	26.78 ± 0.02^f

Results are means ± SEM of eight independent determinations. Values in the same row carrying different superscripts are significant (𝑃<0.05) from each other.
Note. P-CTR: positive control mice; N-CTR: negative control mice; AQ₁₀₀: infected group treated with 100 mg/kg G. lucidum; AQ₂₅₀: infected group treated with 250 mg/kg G. lucidum; AQ₅₀₀: infected mice treated with 500 mg/kg G. lucidum; CQ: infected mice treated with chloroquine.